Recruiting Pulmonary Embolism Studies in Buenos Aires
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study w...
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
This is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of SAR442970 in comparison ...
About Pulmonary Embolism Clinical Trials in Buenos Aires
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Buenos Aires, . These studies are seeking a combined 207 participants. Research is being sponsored by GlaxoSmithKline, Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Buenos Aires — FAQ
Are there pulmonary embolism clinical trials in Buenos Aires?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Buenos Aires, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Buenos Aires?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buenos Aires research site will contact you about next steps.
Are clinical trials in Buenos Aires free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buenos Aires studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Buenos Aires are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov